Business Daily from THE HINDU group of publications Saturday, Apr 05, 2008 ePaper | Mobile/PDA Version |
|
|
|
|
|
|
|
Money & Banking
-
Credit Market Industry & Economy - Pharmaceuticals
G. Naga Sridhar
Hyderabad, April 4 The Small and Medium Enterprises (SMEs) in pharmaceuticals industry can now look forward to financial assistance to meet the mandatory environmental norms, thanks to an exclusive term loan product being offered by the State Bank of India (SBI). All the bulk drug manufacturers should ensure compliance to ‘Schedule M’ (for clearance from environmental authorities). This is also important for other certifications from US Food and Drug Administration (US FDA) and Good Manufacturing Practices (GMP) required for exports. Andhra pilot“We have just launched the product on a pilot basis in Andhra Pradesh in view of the large number of pharma companies here. The extension of the product to other places will be examined later,” Mr Simon Fernandez, Deputy General Manager (SMEs), State Bank of India told Business Line here. The term loan would also help SME drug manufacturers to fulfil the eco norms for up gradation of their capacities, and it is the first time that a major bank has launched an exclusive loan for meeting these requirements. It increases the repayment period by two years i.e. longer repayment period with moratorium of 2 years as it takes normally 18-24 months to get the quality certification and comes with a lower margin (10) per cent from the clients, he added. German collaborationThe design and launch of the product was done by SBI in collaboration with the German Technical Corporation (GTZ). “This is a very crucial offer for the bulk drug industry. The cost of schedule M/Gmp compliance varies among units based on their current level of infrastructure and is estimated to vary between Rs 40 lakh to Rs 1.5 crore. “Similar is the case with upgradation of pollution control equipment. Most of the units need to upgrade their PCEs to meet the current standards,” Mr N. Gurumurthy, Project Manager (Financial Services), GTZ said. More Stories on : Credit Market | Pharmaceuticals | SSI | State Bank of India | Environment
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
![]() |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2008, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|